Liver Cancer

Type: Keyphrase
Name: Liver Cancer
First reported 4 hours ago - Updated 54 mins ago - 1 reports

Cancer treatment by radio waves now in Karachi

KarachiLatest cancer treatment by radiofrequency ablation (RFA) is successfully being done at the Ziauddin University Hospital, North Campus, The News has learnt.The treatment is particularly effective in destroying liver and bone tumours in patients ... [Published The News International - 4 hours ago]
Entities: Karachi, Tumor, Cancer
First reported 6 hours ago - Updated 4 hours ago - 1 reports

Dry July not just about the booze

Seeing her husband go through cancer treatment for the second time is harrowing enough. But Tina King-Garde has found the strength to do this while going without her food loves for a month - chocolate and sweets - for the Dry July fundraiser.The fundraiser ... [Published Daily Telegraph Australia - North Shore - 6 hours ago]
First reported 12 hours ago - Updated 6 hours ago - 2 reports

Mobilizing to Reduce Hepatitis C in the Black Community: July 25 Is National African American Hepatitis C Action Day

Hepatitis C infection is a major public health concern for people of all races, and it has become one of the leading causes of death associated with liver cancer in the United States. Hepatitis C is more prevalent in the African American population than ... [Published Huffington Post - 6 hours ago]
First reported 11 hours ago - Updated 11 hours ago - 1 reports

How One Man Is Saying Good-Bye To His Dog With The Sweetest Bucket List

This is puppy love. Two weeks ago, James Garcia's dog Elmo was diagnosed with liver cancer, bladder disease, and renal failure. facebook.com James has had Elmo since he was a puppy — he's almost 16-years-old now—and couldn't bear to think about ... [Published BuzzFeed - Latest - 11 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient

Petah-Tikva, Israel -- ( SBWIRE ) -- 07/22/2014 -- Can-Fite BioPharma Ltd, a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health ... [Published SBWire - 12 hours ago]
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Primary liver cancer subtype incidence grew in deprived areas of England

Incidence of liver cell and intrahepatic bile duct carcinomas increased over time among men and women in areas of deprivation in England, according to results from a new study.Julie Konfortion, MSc, of the Knowledge and Intelligence Team, Public Health ... [Published Orthopedics Today - 17 hours ago]
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Media Advisory: GenSpera's G-202 HCC Clinical Trial Presentation from 5th Asia-Pacific Primary Liver Cancer Expert (APPLE) Meeting Available

SAN ANTONIO, July 22, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE) presentation of the G-202 hepatocellular ... [Published PR Newswire: Financial Services - 20 hours ago]
First reported Jul 21 2014 - Updated 21 hours ago - 1 reports

Florida Health Department Celebrates World Hepatitis Day

Statistics from the Centers for Disease Control show 75 percent of adults infected with hepatitis are adults born between 1945 and 1965.While anyone can get Hepatitis C, Baby Boomers are five times more likely to have the disease and most don't know they ... [Published WJHG - Jul 21 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Prolactin deters liver cancer [Medical Sciences]

Hadley J. Hartwell a , b , Keiko Y. Petrosky c , James G. Fox d , Nelson D. Horseman e , and Arlin B. Rogers a , 1 a Department of Biomedical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536; b Lineberger ... [Published PNAS - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Liver Cancer Without Cirrhosis Surprisingly Common: Is NAFLD the Cause?

CHICAGO – A full 13% of patients diagnosed with hepatocellular carcinoma did not have underlying cirrhosis in a national sample of 1,500 veterans.Although hepatocellular carcinoma (HCC) in patients... ... [Published Clinician Reviews - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 3 reports

World Hepatitis Day is a time to rethink the future impact of untreated Hepatitis C in Ontario

. Please consider this article from the Canadian Liver Foundation for publication or online.)TORONTO, July 21, 2014 /CNW/ - Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), spread through the exchange of blood. In time, HCV can cause ... [Published BusinessWeek - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 2 reports

Malaria drug could prevent liver cancer

An over-the-counter malarial drug could prevent liver cancer and shrink established tumours, British scientists have found.Scientists at University College London (UCL) have discovered that a commonly-used and inexpensive derivative of quinine, Chloroquine, ... [Published Pharma Field - Jul 21 2014]

Quotes

"The award was also made possible because of the amazing extended community around us."
"They could put their foot down, deny coverage for the drug and let massive protests from patients' ensue. But they haven't done that. While many publicly oppose the high price, they have also decided it's something they need to offer patients. And, even though they don't like the high price for Sovaldi, at the end of the day, they're willing to pay for the value it provides."
"I never wanted him to feel lonely in the apartment and he loves the outdoors so much," James told BuzzFeed. "He goes with me to restaurants, grocery shopping and naps in the park."
...We are told by his doctor that he is in strong and stable health and we wish him continued wellbeing," stated Can-Fite CEO Dr. Pnina Fishman. "We believe that the very favorable safety data from our Phase I II trial may have been a key factor in the MOH's decision to approve CF102 for compassionate use."

More Content

All (1186) | News (1020) | Reports (0) | Blogs (155) | Audio/Video (0) | Fact Sheets (3) | Press Releases (7)
sort by: Date | Relevance
VIRAL VULNERABILITY [Published The Statesman - 1 hour ago]
The Sad Demise of Nancy Lee, One of Britain's K... [Published Vice UK - 1 hour ago]
Cancer treatment by radio waves now in Karachi [Published The News International - 4 hours ago]
Global award for cancer warriors [Published Penrith Star - 5 hours ago]
Dry July not just about the booze [Published Daily Telegraph Australia - North Shore - 6 hours ago]
Mobilizing to Reduce Hepatitis C in the Black C... [Published Huffington Post - 6 hours ago]
A life-saving cure with an $84,000 price tag [Published BBC - 9 hours ago]
3 Longtime Losers About to See Green? [Published Motley Fool - 11 hours ago]
How One Man Is Saying Good-Bye To His Dog With ... [Published BuzzFeed - Latest - 11 hours ago]
Can-Fite's CF102 Approved for Compassionate Use... [Published SBWire - 12 hours ago]
July 28: World Hepatitis Awareness Day [Published Noodls - 12 hours ago]
Shoprite, Foundation screen 600 women for breas... [Published The Guardian Nigeria - 13 hours ago]
MMK to Feature the Story of Cancer Patient Rowd... [Published Philippine News - 14 hours ago]
Easing Drug-Induced Fatty Liver Disease in HIV ... [Published Drug Discovery and Development - 14 hours ago]
Celsion's EGEN Acquisition Brings Immunotherapy... [Published Seeking Alpha - 14 hours ago]
New study shows heavy comorbidity burden for os... [Published Arthritis Research UK - 15 hours ago]
KU docs say proposed cure for transplant waits ... [Published KCPT Magazine - 17 hours ago]
Primary liver cancer subtype incidence grew in ... [Published Orthopedics Today - 17 hours ago]
WHO/IARC Delegate, Dr. Maimuna Mendy Visits Bre... [Published Peace FM - 18 hours ago]
Tesamorelin, which reduces abdominal fat in HIV... [Published Pharma Letter - 18 hours ago]
RPC 2014 Annual Meeting held in Shanghai [Published China Association for Science and Technology - 19 hours ago]
Media Advisory: GenSpera's G-202 HCC Clinical T... [Published PR Newswire: Financial Services - 20 hours ago]
Enzyme may halt tumor growth in kidney cancer [Published Medical News Today - 20 hours ago]
Celsion gets $1 mn career development award gra... [Published PharmaBiz - 20 hours ago]
'Deal with it' documentary Exposes Canada's Hid... [Published Morningstar.com - 22 hours ago]
Hepatitis QLD makes plea in fight against virus [Published Bio Spectrum Asia - Jul 22 2014]
Prolactin deters liver cancer [Medical Sciences] [Published PNAS - Jul 22 2014]
Incidence of Second Malignancies for Prostate C... [Published Plosone.org - Jul 22 2014]
Enzyme That Stops Progression of Kidney Cancer:... [Published International Business Times Australia - Jul 22 2014]
Remembering radio's Jim Healy, the #@*# greates... [Published Los Angeles Times - Jul 22 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
How One Man Is Saying Good-Bye To His Dog With ... [Published BuzzFeed - Latest - 11 hours ago]
This is puppy love. Two weeks ago, James Garcia's dog Elmo was diagnosed with liver cancer, bladder disease, and renal failure. facebook.com James has had Elmo since he was a puppy — he's almost 16-years-old now—and couldn't bear to think about ...
Media Advisory: GenSpera's G-202 HCC Clinical T... [Published PR Newswire: Financial Services - 20 hours ago]
SAN ANTONIO, July 22, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, announces the Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE) presentation of the G-202 hepatocellular ...
GenSpera Presents G-202 HCC Clinical Trial Upda... [Published PR Newswire: Financial Services - Jul 15 2014]
SAN ANTONIO, July 15, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the APPLE 2014 presentation. Devalingam Mahalingam, MD, PhD, Principal Investigator of the G-202 ...
The Price of Compassion - Commercialized Hospic... [Published Health Care Renewal - Jul 10 2014]
Introduction - Commercialized Hospices We have occasionally written about the rise of the commercialized hospice industry, and concerns that commercialized hospices may not be providing the compassionate care they promise.  As we have discussed before ...
Can-Fite's CF102 Approved for Compassionate Use... [Published PR Newswire: Health - Jul 10 2014]
PETACH TIKVA, Israel, July 10, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
NeoStem Announces Licensing Agreement and Plans... [Published GlobeNewswire: Acquisitions News - May 13 2014]
Cellular Biomedicine Group Releases Positive Re... [Published GlobeNewswire: Advertising News - Mar 24 2014]
Delcath Systems Analyst Report by BrokerBank Se... [Published Financial Services - Mar 24 2014]
Guerbet and Sirtex to Collaborate on Clinical S... [Published GlobeNewswire: Acquisitions News - Mar 24 2014]
Biostar Pharmaceuticals, Inc. Partners with Sha... [Published Financial Services - Mar 06 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.